TRxADE HEALTH Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-3.47	-5.32	-2.54	-0.28	0.01	0.29	-2.76	-1.12	-2.01	-2.09
Depreciation & Amortization	0.2	0.14	0.1	0.09	0	0	0	0	0	0
Share-Based Compensation	0.33	0.37	1.81	0.18	0.17	0.28	0.15	0.36	0.37	0.46
Other Operating Activities	1.42	2.24	-1.59	0.16	0.09	-0.4	2.11	0.85	0.57	0.78
Operating Cash Flow	-1.53	-2.57	-2.21	0.14	0.27	0.17	-0.5	0.09	-1.06	-0.84
Operating Cash Flow Growth	-	-	-	-48.14%	59.25%	-	-	-	-	-
Capital Expenditures	-0.43	-0.02	-0.04	-0.08	-0.02	0	0	0	0	0.01
Acquisitions	0	0	0	0	-0.25	0	0	0	0	0
Change in Investments	0	0	0	-0.25	0	0	0	0	0	0
Investing Cash Flow	-0.43	-0.02	-0.04	-0.33	-0.27	0	0	0	0	0.01
Share Issuance / Repurchase	0.13	0.02	5.3	2.46	0.8	0.25	0.3	0	1.36	0.37
Debt Issued / Paid	0.83	-0.23	0	-0.26	-0.12	-0.25	0.37	0.41	-0.05	0.05
Other Financing Activities	-0.99	-	-	-	-	-	-0.04	0	0.38	0.51
Financing Cash Flow	-0.04	-0.21	5.3	2.19	0.68	-0	0.62	0.41	1.69	0.94
Net Cash Flow	-1.99	-2.8	3.05	2	0.69	0.17	-0.06	-0.62	0.62	0.08
Free Cash Flow	-1.95	-2.59	-2.25	0.06	0.26	0.17	-0.5	0.09	-1.06	-0.83
Free Cash Flow Growth	-	-	-	-76.96%	50.51%	-	-	-	-	-
Free Cash Flow Margin	-17.07%	-26.18%	-13.15%	0.80%	6.74%	5.86%	-20.29%	3.10%	-71.15%	-87.21%
Free Cash Flow Per Share	-3.46	-4.77	-4.38	0.15	0.72	0.48	-1.44	0.26	-3.21	-5.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).